Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Stats
Policies
About
Home
Browse
Latest
Stats
Policies
About
ePrints
Browsing publications by
Peter Curtis
Newcastle Authors
Title
Year
Full text
Professor Georg Lietz
Peter Curtis
Professor John Mathers
Dr Franck Tourniaire
CD36 and SR-BI Are Involved in Cellular Uptake of Provitamin A Carotenoids by Caco-2 and HEK Cells, and Some of Their Genetic Variants Are Associated with Plasma Concentrations of These Micronutrients in Humans
2013
Peter Curtis
Professor Georg Lietz
Professor John Mathers
Apolipoprotein E genotype and the cardiovascular disease risk phenotype: Impact of sex and adiposity (the FINGEN study)
2012
Peter Curtis
Professor Ashley Adamson
Professor John Mathers
Effects on nutrient intake of a family-based intervention to promote increased consumption of low-fat starchy foods through education, cooking skills and personalised goal setting: the Family Food and Health Project
2012
Professor Georg Lietz
Peter Curtis
Julie Stannard
Professor John Mathers
Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study
2008
Peter Curtis
Professor Philip Home
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)
2008
Professor Philip Home
Peter Curtis
Rosiglitazone RECORD study: Glucose control outcomes at 18 months
2007
Professor Philip Home
Peter Curtis
[abstract] Prolonged efficacity on 12 months of rosiglitazone given in association on ambulatory arterial stiffness in patients suffering type 2 diabetes
2006
Peter Curtis
Professor Philip Home
Randomized controlled trial of the effect of rosiglitazone in combination therapy on ambulatory blood pressure in people with type 2 diabetes mellitus followed for 12 months
2005
Peter Curtis
Professor Philip Home
Rosiglitazone combination therapy lowers ambulatory blood pressure (ABP) over a twelve month period in patients with Type 2 diabetes mellitus
2005
Professor Philip Home
Peter Curtis
Rosiglitazone combination therapy improves ambulatory blood pressure: A 6-month substudy of the RECORD trial in people with type 2 diabetes
2004
1
2